Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Disease and MEF2B[original query]
EZH2 mutations are frequent and represent an early event in follicular lymphoma.
Blood 2013 Oct 122 (18): 3165-8.
Bödör Csaba, Grossmann Vera, Popov Nikolay, Okosun Jessica, O'Riain Ciarán, Tan King, Marzec Jacek, Araf Shamzah, Wang Jun, Lee Abigail M, Clear Andrew, Montoto Silvia, Matthews Janet, Iqbal Sameena, Rajnai Hajnalka, Rosenwald Andreas, Ott German, Campo Elias, Rimsza Lisa M, Smeland Erlend B, Chan Wing C, Braziel Rita M, Staudt Louis M, Wright George, Lister T Andrew, Elemento Olivier, Hills Robert, Gribben John G, Chelala Claude, Matolcsy András, Kohlmann Alexander, Haferlach Torsten, Gascoyne Randy D, Fitzgibbon Ju
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
The Lancet. Oncology 2015 Sep 16 (9): 1111-22.
Pastore Alessandro, Jurinovic Vindi, Kridel Robert, Hoster Eva, Staiger Annette M, Szczepanowski Monika, Pott Christiane, Kopp Nadja, Murakami Mark, Horn Heike, Leich Ellen, Moccia Alden A, Mottok Anja, Sunkavalli Ashwini, Van Hummelen Paul, Ducar Matthew, Ennishi Daisuke, Shulha Hennady P, Hother Christoffer, Connors Joseph M, Sehn Laurie H, Dreyling Martin, Neuberg Donna, Möller Peter, Feller Alfred C, Hansmann Martin L, Stein Harald, Rosenwald Andreas, Ott German, Klapper Wolfram, Unterhalt Michael, Hiddemann Wolfgang, Gascoyne Randy D, Weinstock David M, Weigert Oliv
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
Blood 2017 11 131 (2): 226-235.
Mottok Anja, Jurinovic Vindi, Farinha Pedro, Rosenwald Andreas, Leich Ellen, Ott German, Horn Heike, Klapper Wolfram, Boesl Michael, Hiddemann Wolfgang, Steidl Christian, Connors Joseph M, Sehn Laurie H, Gascoyne Randy D, Hoster Eva, Weigert Oliver, Kridel Robe
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Cancer science 2021 Nov .
Rai Shinya, Inoue Hiroaki, Sakai Kazuko, Hanamoto Hitoshi, Matsuda Mitsuhiro, Maeda Yasuhiro, Haeno Takahiro, Watatani Yosaku, Kumode Takahiro, Serizawa Kentaro, Taniguchi Yasuhiro, Hirase Chikara, Espinoza J Luis, Morita Yasuyoshi, Tanaka Hirokazu, Ashida Takashi, Tatsumi Yoichi, Nishio Kazuto, Matsumura Ita
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas.
Cancer research and treatment 2022 Mar .
Kim Seok Jin, Kim Yeon Jeong, Yoon Sang Eun, Ryu Kyung Ju, Park Bon, Park Donghyun, Cho Duck, Kim Hyun-Young, Cho Junhun, Ko Young Hyeh, Park Woong-Yang, Kim Won Se
Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma.
Journal of blood medicine 2024 9 15 407-419.
Jing Wang, Lei Tian, Weilong Zhang, Shuhan Tang, Wei Zhao, Yu Guo, Chaoling Wu, Yuansheng Lin, Xiaoyan Ke, Hongmei Ji
TOP